Academic Journal
NPC1L1 Plays a Novel Role in Nonalcoholic Fatty Liver Disease
| العنوان: | NPC1L1 Plays a Novel Role in Nonalcoholic Fatty Liver Disease |
|---|---|
| المؤلفون: | ChongLi Xu, Fengyang Fu, Yuhan She, ChongBo Xu |
| سنة النشر: | 2023 |
| مصطلحات موضوعية: | Biochemistry, Medicine, Cell Biology, Genetics, Physiology, Pharmacology, Computational Biology, Chemical Sciences not elsewhere classified, steroid hormone synthesis, molecular pathological mechanism, intestinal epithelial cells, timid duct membrane, brush marginal membrane, density lipoprotein levels, affects cholesterol absorption, regulate lipid metabolism, reduce liver steatosis, abnormal cholesterol metabolism, lipid metabolism, cholesterol metabolism, cell membrane, multiple levels, serious consequences, plasma low, pick c1, novel role, nonalcoholic steatohepatitis, like 1, key protein, important role |
| الوصف: | Niemann-Pick C1-Like 1 (NPC1L1) is a key protein in the transport of cholesterol, which exists in the brush marginal membrane of the intestinal epithelial cells and the timid duct membrane of the liver. It affects cholesterol absorption and plasma low-density lipoprotein levels. Cholesterol is both an important component of the cell membrane and a precursor of bile acid and steroid hormone synthesis. Abnormal cholesterol metabolism is closely related to nonalcoholic steatohepatitis (NASH). NASH can progress to fibrosis and cirrhosis, with serious consequences. NPC1L1 is involved in the regulation of cholesterol and lipid metabolism and plays an important role in maintaining the balance of cholesterol metabolism in the body. It also plays an important role in some metabolic diseases such as nonalcoholic fatty liver disease, obesity, and hypercholesterolemia. Therefore, it is necessary to elucidate the molecular pathological mechanism of NPC1L1 in the regulation of cholesterol metabolism and the occurrence and development of NASH, which can provide a target for the development of novel drugs for the treatment of NASH and other diseases. More importantly, it helps to accelerate the development of drugs that regulate lipid metabolism at multiple levels and reduce liver steatosis, which is extremely important for the prevention and treatment of NASH and related severe metabolic diseases. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | unknown |
| Relation: | https://figshare.com/articles/journal_contribution/NPC1L1_Plays_a_Novel_Role_in_Nonalcoholic_Fatty_Liver_Disease/24802739 |
| DOI: | 10.1021/acsomega.3c07337.s001 |
| الاتاحة: | https://doi.org/10.1021/acsomega.3c07337.s001 https://figshare.com/articles/journal_contribution/NPC1L1_Plays_a_Novel_Role_in_Nonalcoholic_Fatty_Liver_Disease/24802739 |
| Rights: | CC BY-NC 4.0 |
| رقم الانضمام: | edsbas.6D6E32F0 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1021/acsomega.3c07337.s001 |
|---|